Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase (original) (raw)
Abstract
Werner Syndrome (WRN) is an autosomal recessive disorder showing an endogenous mutator phenotype in combination with an elevated risk of predominantly mesenchymal cancer. The gene mutated in WRN patients codes for 3’→5’ DNA helicase and 3’→5’ exonuclease activities. We have found similar S-phase arrest in both WRN and control cells after treatment with the DNA-topoisomerase-I-trapping drug camptothecin; this may be responsible for the drug-exposure-related growth inhibition seen in both cell types. A clearer phenotypic difference between WRN and control immortalized B-cell lines (LCLs) is obtained by examining cell death. The mechanism of camptothecin-induced cell death in WRN-deficient LCLs appears to be through apoptosis, a phenotype that strongly differentiates WRN-deficient from wild-type LCLs. We hypothesize that, in cells deficient for WRN function, a topoisomerase-I-DNA intermediate persists. Conflict with DNA replication may lead to apoptosis, increased mutation rates, and cancer in WRN.
Access this article
Subscribe and save
- Starting from 10 chapters or articles per month
- Access and download chapters and articles from more than 300k books and 2,500 journals
- Cancel anytime View plans
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Pathology, University of Washington, Mail Box 357 705, Seattle, WA 98195-7705, USA Tel.: (206) 616-8716, Fax: (206) 616-8271 e-mail: mpoot@u.washington.edu, , , , , , US
M. Poot, Katherine A. Gollahon & Peter S. Rabinovitch
Authors
- M. Poot
- Katherine A. Gollahon
- Peter S. Rabinovitch
Additional information
Received: 23 September 1998 / Accepted: 26 October 1998
Rights and permissions
About this article
Cite this article
Poot, M., Gollahon, K. & Rabinovitch, P. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase.Hum Genet 104, 10–14 (1999). https://doi.org/10.1007/s004390050903
- Issue date: February 1999
- DOI: https://doi.org/10.1007/s004390050903